PTC Therapeutics Provides an Update on Commercial Progress a

– Unaudited 2023 total revenue of $946 million, representing 35% year-over-year growth –
– Regulatory filings in the EU and US for sepiapterin in PKU, a potential $1 billion global commercial...

Related Keywords

Brazil , Russia , United States , Kylie Okeefe , Matthewb Klein , Jeanine Clemente , Nasdaq , Instagram , Twitter , European Medicines Agency , Therapeutics Inc , Blackstone Life Sciences , Committee For Medicinal Products Human , Facebook , European Commission , Drug Administration , Linkedin , Healthcare Conference , Chief Executive Officer , Royalty Pharma , Blackstone Life , Key Clinical , Regulatory Events , Full Year , Payments Full Year , Consideration Payable Related Milestone , Aromatici Amino Acid , Amyotrophic Lateral , Biologics License , Medicinal Products , Duchenne Muscular , European Medicines , Marketing Authorization , New Drug , Spinal Muscular , More Information , Looking Statements , Private Securities Litigation Reform Act , European Economic Area , Quarterly Report , Annual Report , Markets ,